HRT Financial’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-37,244
Closed -$18K 3368
2023
Q2
$18K Buy
+37,244
New +$30.5K ﹤0.01% 2109
2022
Q3
Sell
-96,456
Closed -$479K 3727
2022
Q2
$479K Buy
96,456
+16,162
+20% +$84.7K 0.01% 1681
2022
Q1
$570K Buy
+80,294
New +$664K ﹤0.01% 1548

Other funds holding CELL

HRT Financial's CELL Position: Q3 2023 in Review

HRT Financial sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 37,244 shares — an estimated $18K sold.

HRT Financial first reported a position in CELL in Q1 2022 and held it in 3 quarters. The position peaked at $570K in Q1 2022. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • HRT Financial reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 37,244 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $18K.
  • HRT Financial first reported a position in PhenomeX Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • HRT Financial's PhenomeX Inc. Common Stock position peaked at $570K in Q1 2022.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.